Literature DB >> 19763209

Seizures and Epilepsy following Aneurysmal Subarachnoid Hemorrhage : Incidence and Risk Factors.

Kyu-Sun Choi1, Hyoung-Joon Chun, Hyeong-Joong Yi, Yong Ko, Young-Soo Kim, Jae-Min Kim.   

Abstract

OBJECTIVE: Although prophylactic antiepileptic drug (AED) use in patients with aneurysmal subarachnoid hemorrhage (SAH) is a common practice, lack of uniform definitions and guidelines for seizures and AEDs rendered this prescription more habitual instead of evidence-based manner. We herein evaluated the incidence and predictive factors of seizure and complications about AED use.
METHODS: From July 1999 to June 2007, data of a total of 547 patients with aneurysmal SAH who underwent operative treatments were reviewed. For these, the incidence and risk factors of seizures and epilepsy were assessed, in addition to complications of AEDs.
RESULTS: Eighty-three patients (15.2%) had at least one seizure following SAH. Forty-three patients (7.9%) had onset seizures, 34 (6.2%) had perioperative seizures, and 17 (3.1%) had late epilepsy. Younger age (< 40 years), poor clinical grade, thick hemorrhage, acute hydrocephalus, and rebleeding were related to the occurrence of onset seizures. Cortical infarction and thick hemorrhage were independent risk factors for the occurrence of late epilepsy. Onset seizures were not predictive of late epilepsy. Moreover, adverse drug effects were identified in 128 patients (23.4%) with AEDs.
CONCLUSION: Perioperative seizures are not significant predictors for late epilepsy. Instead, initial amount of SAH and surgery-induced cortical damage should be seriously considered as risk factors for late epilepsy. Because AEDs can not prevent early postoperative seizures (< 1 week) and potentially cause unexpected side effects, long-term use should be readjusted in high-risk patients.

Entities:  

Keywords:  Aneurysm; Antiepileptic drug; Complication; Epilepsy; Risk factors; Seizure

Year:  2009        PMID: 19763209      PMCID: PMC2744032          DOI: 10.3340/jkns.2009.46.2.93

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  29 in total

1.  PREDICTING EPILEPSY AFTER BLUNT HEAD INJURY.

Authors:  W B JENNETT
Journal:  Br Med J       Date:  1965-05-08

2.  Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxis.

Authors:  A M Haltiner; D W Newell; N R Temkin; S S Dikmen; H R Winn
Journal:  J Neurosurg       Date:  1999-10       Impact factor: 5.115

3.  Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage.

Authors:  D H Rhoney; L B Tipps; K R Murry; M C Basham; D B Michael; W M Coplin
Journal:  Neurology       Date:  2000-07-25       Impact factor: 9.910

4.  Neurological and psychosocial outcome 4 to 7 years after subarachnoid hemorrhage.

Authors:  J A Ogden; T Utley; E W Mee
Journal:  Neurosurgery       Date:  1997-07       Impact factor: 4.654

5.  Seizures at the onset of subarachnoid haemorrhage.

Authors:  A N Pinto; P Canhao; J M Ferro
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

6.  Epileptic seizures after subarachnoid hemorrhage.

Authors:  D Hasan; R S Schonck; C J Avezaat; H L Tanghe; J van Gijn; P J van der Lugt
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

7.  Short-term perioperative anticonvulsant prophylaxis for the surgical treatment of low-risk patients with intracranial aneurysms.

Authors:  C J Baker; C J Prestigiacomo; R A Solomon
Journal:  Neurosurgery       Date:  1995-11       Impact factor: 4.654

8.  Risk of epilepsy after aneurysm operations.

Authors:  J Bidziński; A Marchel; A Sherif
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

9.  Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs.

Authors:  Axel J Rosengart; J Dezheng Huo; Jocelyn Tolentino; Roberta L Novakovic; Jeffrey I Frank; Fernando D Goldenberg; R Loch Macdonald
Journal:  J Neurosurg       Date:  2007-08       Impact factor: 5.115

10.  International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.

Authors:  Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

View more
  15 in total

Review 1.  Incidence, Implications, and Management of Seizures Following Ischemic and Hemorrhagic Stroke.

Authors:  Joseph W Doria; Peter B Forgacs
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-27       Impact factor: 5.081

Review 2.  Seizures and anticonvulsants after aneurysmal subarachnoid hemorrhage.

Authors:  Giuseppe Lanzino; Pietro Ivo D'Urso; Jose Suarez
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

3.  Unusual appearance of facial petechiae and conjunctival hemorrhages: the trout phenomenon in a case of fatal subarachnoid hemorrhage due to ruptured berry aneurysm.

Authors:  Danica Cvetković; Vladimir Živković; Slobodan Nikolić
Journal:  Forensic Sci Med Pathol       Date:  2016-10-26       Impact factor: 2.007

Review 4.  Intracranial hemorrhage.

Authors:  J Alfredo Caceres; Joshua N Goldstein
Journal:  Emerg Med Clin North Am       Date:  2012-08       Impact factor: 2.264

5.  Safety and tolerability of gabapentin for aneurysmal subarachnoid hemorrhage (sah) headache and meningismus.

Authors:  Laxmi P Dhakal; David O Hodge; Jay Nagel; Jay Nagal; Michael Mayes; Alexa Richie; Lauren K Ng; William D Freeman
Journal:  Neurocrit Care       Date:  2015-06       Impact factor: 3.210

6.  Frequency of non-convulsive seizures and non-convulsive status epilepticus in subarachnoid hemorrhage patients in need of controlled ventilation and sedation.

Authors:  Cecilia Lindgren; Erik Nordh; Silvana Naredi; Magnus Olivecrona
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

7.  Controversies and evolving new mechanisms in subarachnoid hemorrhage.

Authors:  Sheng Chen; Hua Feng; Prativa Sherchan; Damon Klebe; Gang Zhao; Xiaochuan Sun; Jianmin Zhang; Jiping Tang; John H Zhang
Journal:  Prog Neurobiol       Date:  2013-09-25       Impact factor: 11.685

Review 8.  Emerging Role of Microglia-Mediated Neuroinflammation in Epilepsy after Subarachnoid Hemorrhage.

Authors:  Jingxue Liang; Jiahong Deng; Xiaolin Liang; Jun Wang; Kewan Wang; Hongxiao Wang; Dadi Qian; Hao Long; Kaijun Yang; Songtao Qi
Journal:  Mol Neurobiol       Date:  2021-01-26       Impact factor: 5.590

Review 9.  Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.

Authors:  Michael N Diringer; Thomas P Bleck; J Claude Hemphill; David Menon; Lori Shutter; Paul Vespa; Nicolas Bruder; E Sander Connolly; Giuseppe Citerio; Daryl Gress; Daniel Hänggi; Brian L Hoh; Giuseppe Lanzino; Peter Le Roux; Alejandro Rabinstein; Erich Schmutzhard; Nino Stocchetti; Jose I Suarez; Miriam Treggiari; Ming-Yuan Tseng; Mervyn D I Vergouwen; Stefan Wolf; Gregory Zipfel
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

10.  High risk for seizures following subarachnoid hemorrhage regardless of referral bias.

Authors:  Kathryn L O'Connor; M Brandon Westover; Michael T Phillips; Nicolae A Iftimia; Deidre A Buckley; Christopher S Ogilvy; Mouhsin M Shafi; Eric S Rosenthal
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.